Autism is a complex, heterogeneous condition with skyrocketing incidence. It is becoming increasingly clear that a subset of children diagnosed with autism suffer from treatable physical illness. Although autism is diagnosed based on a constellation of behavioral symptoms, when underlying physical illnesses are identified and treated properly, children can reach their maximum potential and are […]
Relevance of BH4 NOS Ammonia and Neurotransmitters in Prevention and Recovery of ASD/PANS through pathway planning and immune shifting Looking more closely at specific mutations and BH4 cycle relevant to causation of autism spectrum and related disorders. BH4 is necessary for neurotransmitter formation and for working across NOS in clearing ammonia and towards Mitochondria for […]
This presentation will summarize the results of a Phase 1 trial of microbiota transplant therapy (MTT) for children with autism, and the results of a new study of MTT for children with Pitt Hopkins. MTT is an investigational therapy involving pretreatment with vancomycin, then a bowel cleanse, and then 8-12 weeks of microbiota from healthy humans. The effect of MTT on gastrointestinal and autism-related symptoms will be presented. This is the first clinical trial ever conducted for Pitt Hopkins. Speaker: James Adams, […]
